Rhode Island's Opioid Epidemic Response Features Collaborative Practice Model
Thu, 24 Jul 2014 00:00:00 -0400
The response to Rhode Island's crisis of opioid-related overdose deaths includes a collaborative practice model through which a single physician authorizes the dispensing of naloxone kits at multiple pharmacies to anyone who may encounter an overdose victim.
Brushwood Retires as AJHP Contributing Editor
After 41 installments of Case Law and 23 years, David B. Brushwood, B.S.Pharm., J.D., on June 28 retired as the AJHP contributing editor for pharmacy law.
Idelalisib Approved for Three Blood Cancers
Wed, 23 Jul 2014 00:00:00 -0400
FDA today announced the approval of idelalisib oral tablets for the treatment of three types of blood cancer that have relapsed after previous therapy.
Discussion Continues on Content, Format of Consumer Drug Leaflets
FDA has made some
progress toward improving consumer information leaflets for prescription drugs,
officials said during a July 1 policy forum held at the Brookings Institution
in Washington, D.C.
Baxter Recalls Four Lots of I.V. Solutions
Fri, 18 Jul 2014 00:00:00 -0400
Baxter International Inc. is recalling two lots of 100-mL 0.9% sodium chloride injection, one lot of 50-mL 0.9% sodium chloride injection, and one lot of 50-mL potassium chloride injection 400 meq/L, according to a notice posted July 16 by FDA.